Emadullah Raidullah/LinkedIn
Sep 28, 2026, 09:25
Emadullah Raidullah: Thrombophilia Workup and PNH Screening When Testing Matters
Emadullah Raidullah, Member of American Society of Hematology, shared a post on LinkedIn:
“Honoured to have spoken at ADHAR 2026 on:
‘Thrombophilia Workup and PNH Screening: Who to Test, When to Test, and When Testing Can Do Harm.’
- Right patient: Test when results may change management.
- Right time: Acute thrombosis and anticoagulants can distort results.
- Don’t miss APS: Triple positive APS generally warrants warfarin over DOACs.
- Think PNH: Consider screening in unusual site thrombosis, hemolysis, or cytopenias.
- Avoid harm: Inappropriate testing can lead to false diagnoses, unnecessary lifelong anticoagulation, and anxiety.
The goal is not to test more , it is to test better.”
Stay updated with Hemostasis Today.
-
Sep 28, 2026, 03:59Rahul Saha: JAMA The 49th Human Blood Group System
-
Sep 28, 2026, 01:51Ann Mullally: Expect to See Lots More Gene Therapy in Medicine in the Years Ahead
-
Sep 27, 2026, 15:49Rana Al-Hrout: Iron Deficency – Is Ferritin 15ng/mL or Less Still the Cutoff?
-
Sep 27, 2026, 15:49Ayushi Sharma: What I Thought Transfusion Medicine Would Be vs What It Actually Is
-
Sep 27, 2026, 15:48William Wallace: How Much Human Research Is Behind the Supplements We Take?
-
Sep 27, 2026, 15:46Franck Perraudin: Lp(a) Lowering Alone May Not Be Enough
-
Sep 27, 2026, 15:41Ahmed Hamandi: Sharing Real-World HSCT Experience at the Iraqi Society of Haematology Conference
-
Sep 27, 2026, 15:39Co-creating Digital Support With Young Stroke Survivors – European Stroke Organisation
-
Sep 27, 2026, 15:39Eleri Schiavone: Celebrating 80 Years of the Welsh Blood Service